Impact of prophylactic/preemptive donor lymphocyte infusion and intensified conditioning for relapsed/refractory leukemia: a real-world study-Reference-Cited by-同舟云学术

Impact of prophylactic/preemptive donor lymphocyte infusion and intensified conditioning for relapsed/refractory leukemia: a real-world study

Published:2020-02-17 Issue:10 Volume:63 Page:1552-1564
ISSN:1674-7305
Container-title:Science China Life Sciences
language:en
Short-container-title:Sci. China Life Sci.

Author:

Wang Yu,Liu Qi-Fa,Wu De-Pei,Wang Jing-Bo,Zhang Xi,Wang Heng-Xiang,Gao Feng,Wang Shun-Qing,Sun Zi-Min,Ouyang Jian,Xu Kai-Lin,Gao Su-Jun,Xu Lan-Ping,Yan Chen-Hua,Huang Xiao-Jun

Publisher

Springer Science and Business Media LLC

Subject

General Agricultural and Biological Sciences,General Environmental Science,General Biochemistry, Genetics and Molecular Biology

Link

http://link.springer.com/content/pdf/10.1007/s11427-019-1610-2.pdf

Reference32 articles.

1. Bornhäuser M., Kienast J., Trenschel R., Burchert A., Hegenbart U., Stadler M., Baurmann H., Schäfer-Eckart K., Holler E., Kröger N., et al. (2012). Reduced-intensity conditioning versus standard conditioning before allogeneic haemopoietic cell transplantation in patients with acute myeloid leukaemia in first complete remission: a prospective, open-label randomised phase 3 trial. Lancet Oncol 13, 1035–1044.

2. Dickinson A.M., Norden J., Li S., Hromadnikova I., Schmid C., Schmetzer H., and Jochem-Kolb H. (2017). Graft-versus-leukemia effect following hematopoietic stem cell transplantation for leukemia. Front Immunol 8, 496.

3. Duléry R., Ménard A.L., Chantepie S., El-Cheikh J., François S., Delage J., Giannotti F., Ruggeri A., Brissot E., Battipaglia G., et al. (2018). Sequential conditioning with thiotepa in T cell-replete hematopoietic stem cell transplantation for the treatment of refractory hematologic malignancies: comparison with matched related, haplo-mismatched, and unrelated donors. Biol Blood Marrow Transplant 24, 1013–1021.

4. Duval M., Klein J.P., He W., Cahn J.Y., Cairo M., Camitta B.M., Kamble R., Copelan E., de Lima M., Gupta V., et al. (2010). Hematopoietic stem-cell transplantation for acute leukemia in relapse or primary induction failure. J Clin Oncol 28, 3730–3738.

5. Jaiswal S.R., Zaman S., Chakrabarti A., Sen S., Mukherjee S., Bhargava S., Ray K., O’Donnell P.V., and Chakrabarti S. (2016). Improved outcome of refractory/relapsed acute myeloid leukemia after post-transplantation cyclophosphamide-based haploidentical transplantation with myeloablative conditioning and early prophylactic granulocyte colony-stimulating factor-mobilized donor lymphocyte infusions. Biol Blood Marrow Transplant 22, 1867–1873.

Cited by 12 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. RETRACTED ARTICLE: The predictive value of BTG1 for the response of newly diagnosed acute myeloid leukemia to decitabine;Clinical Epigenetics;2024-01-22

2. Salvage hematopoietic stem cell transplantation for patients with higher leukemia burden in relapsed or refractory acute myeloid leukemia: a ten-year study;Annals of Hematology;2023-09-08

3. Real-world experience with selinexor-containing chemotherapy-free or low-dose chemotherapy regimens for patients with relapsed/refractory acute myeloid leukemia and myeloid sarcoma;Frontiers in Pharmacology;2023-08-04

4. Application of prophylactic or pre-emptive therapy after allogeneic transplantation for high-risk patients with t(8;21) acute myeloid leukemia;Hematology;2023-04-27

5. Allogeneic Hematopoietic Stem Cell Transplantation for Acute Lymphoblastic Leukemia;Pathogenesis and Treatment of Leukemia;2023